A novel methylation marker, cg17075888 (PDK4) also seemed intriguing, since this gene was extensively researched for potential therapeutic targets; a PDK4 inhibitor has been reported as a potential drug target for metabolic diseases, such as T2D [37]. The gene discussed is PDK4; the disease is metabolic disease.